M. Navarro

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

J. Squifflet, J. D. de Fijter, W. Weimar, 1998, Transplantation.

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

J. Squifflet, J. D. de Fijter, W. Weimar, 1998, Transplantation.

Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies.

T. Paavonen, M. Navarro, S. Tomlanovich, 2003, Journal of the American Society of Nephrology : JASN.

MULTICENTER TRIAL EXPLORING CALCINEURIN INHIBITORS AVOIDANCE IN RENAL TRANSPLANTATION

B. Nashan, M. Navarro, D. Kuypers, 2001, Transplantation.

Mycophenolate mofetil for the treatment of a first acute renal allograft rejection

M. Pescovitz, D. Conti, P. Keown, 1998 .

Rescue therapy with mycophenolate mofetil

M. Pescovitz, D. Conti, E. Woodle, 1996 .

Immunosuppressive therapy and post‐transplantation diarrhea

M. Pescovitz, M. Navarro, 2001, Clinical transplantation.

The use of mycophenolate mofetil suspension in pediatric renal allograft recipients

B. Chavers, B. Tönshoff, R. Walker, 2001, Pediatric Nephrology.

Protocol core needle biopsy and histological chronic allograft damage index as surrogate endpoint for Long-Term graft survival.

T. Paavonen, M. Navarro, P. Hayry, 2004, Transplantation proceedings.